Assessment of 54 biomarkers in PsA patients initiating Tumour Necrosis Factor alpha inhibitor, Interleukin 17 inhibitor or Methotrxate: an exploratory study

30.07.2021

Investigators

Marie Skougaard1,2, Magnus Friis Søndergaard2, Sisse B. Ditlev2, Lars Erik Kristensen1 1 The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark 2 Copenhagen Center for Translational Research, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark

Contact Person